| P50 | author | Jochen Maurer | Q37374252 |
| | Satyendra C. Tripathi | Q50926692 |
| | Dongya Jia | Q85350964 |
| | Marc P Stemmler | Q88804983 |
| | Jason T George | Q88915489 |
| P2093 | author name string | Herbert Levine | |
| | Samir M Hanash | |
| | Thomas Brabletz | |
| | Mohit Kumar Jolly | |
| | Bogdan-Tiberius Preca | |
| P2860 | cites work | MicroRNA-based regulation of epithelial-hybrid-mesenchymal fate determination | Q24598602 |
| | The ZEB/miR-200 feedback loop--a motor of cellular plasticity in development and cancer? | Q24617121 |
| | A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells | Q24649109 |
| | Implications of the Hybrid Epithelial/Mesenchymal Phenotype in Metastasis | Q26799987 |
| | Anoikis molecular pathways and its role in cancer progression | Q26852158 |
| | Epithelial-mesenchymal plasticity in carcinoma metastasis | Q26859804 |
| | EMT, CTCs and CSCs in tumor relapse and drug-resistance | Q28082935 |
| | TGF-β-induced epithelial-to-mesenchymal transition proceeds through stepwise activation of multiple feedback loops | Q28248954 |
| | Coupled reversible and irreversible bistable switches underlying TGFβ-induced epithelial to mesenchymal transition | Q28297232 |
| | Mammary morphogenesis and regeneration require the inhibition of EMT at terminal end buds by Ovol2 transcriptional repressor | Q28593726 |
| | The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity | Q29547693 |
| | A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition | Q29617690 |
| | Inflammatory breast cancer: a model for investigating cluster-based dissemination. | Q33767606 |
| | EMT cells increase breast cancer metastasis via paracrine GLI activation in neighbouring tumour cells | Q33804808 |
| | EMT and MET: necessary or permissive for metastasis? | Q33869775 |
| | Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer. | Q34045380 |
| | Towards elucidating the connection between epithelial-mesenchymal transitions and stemness | Q34470537 |
| | Stability of the hybrid epithelial/mesenchymal phenotype | Q34519552 |
| | Hypoxia induces epithelial-mesenchymal transition via activation of SNAI1 by hypoxia-inducible factor -1α in hepatocellular carcinoma | Q34622198 |
| | CD44 splice isoform switching in human and mouse epithelium is essential for epithelial-mesenchymal transition and breast cancer progression | Q34627193 |
| | Epithelial-mesenchymal transition spectrum quantification and its efficacy in deciphering survival and drug responses of cancer patients. | Q34880376 |
| | Temporally sequenced anticancer drugs overcome adaptive resistance by targeting a vulnerable chemotherapy-induced phenotypic transition | Q35119820 |
| | Stemness of the hybrid Epithelial/Mesenchymal State in Breast Cancer and Its Association with Poor Survival. | Q35644828 |
| | Matrix stiffness drives epithelial-mesenchymal transition and tumour metastasis through a TWIST1-G3BP2 mechanotransduction pathway. | Q35673817 |
| | ZEB1-associated drug resistance in cancer cells is reversed by the class I HDAC inhibitor mocetinostat. | Q35695410 |
| | A microfluidic device for label-free, physical capture of circulating tumor cell clusters | Q35812039 |
| | An Ovol2-Zeb1 Mutual Inhibitory Circuit Governs Bidirectional and Multi-step Transition between Epithelial and Mesenchymal States | Q35836998 |
| | ZEB1-responsive genes in non-small cell lung cancer | Q35915752 |
| | OVOL guides the epithelial-hybrid-mesenchymal transition. | Q36021039 |
| | ΔNp63α Promotes Breast Cancer Cell Motility through the Selective Activation of Components of the Epithelial-to-Mesenchymal Transition Program | Q36070381 |
| | CellMiner: a web-based suite of genomic and pharmacologic tools to explore transcript and drug patterns in the NCI-60 cell line set. | Q36103111 |
| | An integrated transcriptional regulatory circuit that reinforces the breast cancer stem cell state | Q36221885 |
| | Interrogating the topological robustness of gene regulatory circuits by randomization. | Q36329954 |
| | Coupling the modules of EMT and stemness: A tunable 'stemness window' model | Q36413140 |
| | The ZEB1/miR-200c feedback loop regulates invasion via actin interacting proteins MYLK and TKS5. | Q36413699 |
| | Fluorescence-based alternative splicing reporters for the study of epithelial plasticity in vivo | Q36481221 |
| | Phenotypic Plasticity Determines Cancer Stem Cell Therapeutic Resistance in Oral Squamous Cell Carcinoma | Q36645085 |
| | Immunoproteasome deficiency is a feature of non-small cell lung cancer with a mesenchymal phenotype and is associated with a poor outcome. | Q36710603 |
| | Molecular portraits of epithelial, mesenchymal, and hybrid States in lung adenocarcinoma and their relevance to survival. | Q36839423 |
| | A 3D in vitro model to explore the inter-conversion between epithelial and mesenchymal states during EMT and its reversion. | Q36965198 |
| | HDAC inhibition impedes epithelial-mesenchymal plasticity and suppresses metastatic, castration-resistant prostate cancer. | Q36978594 |
| | Global Decrease of Histone H3K27 Acetylation in ZEB1-Induced Epithelial to Mesenchymal Transition in Lung Cancer Cells | Q37061777 |
| | ZEB1 drives epithelial-to-mesenchymal transition in lung cancer | Q37217422 |
| | Mesenchymal-Epithelial Transition in Sarcomas Is Controlled by the Combinatorial Expression of MicroRNA 200s and GRHL2. | Q37252859 |
| | An EMT spectrum defines an anoikis-resistant and spheroidogenic intermediate mesenchymal state that is sensitive to e-cadherin restoration by a src-kinase inhibitor, saracatinib (AZD0530). | Q37357076 |
| | E-cadherin, beta-catenin, and ZEB1 in malignant progression of cancer | Q37372547 |
| | Paracrine and autocrine signals induce and maintain mesenchymal and stem cell states in the breast | Q37595164 |
| | A novel ZEB1/HAS2 positive feedback loop promotes EMT in breast cancer | Q37706944 |
| | Integrin-β4 identifies cancer stem cell-enriched populations of partially mesenchymal carcinoma cells | Q37730158 |
| | A CD44v+ subpopulation of breast cancer stem-like cells with enhanced lung metastasis capacity | Q37745533 |
| | Regulatory networks defining EMT during cancer initiation and progression | Q38076317 |
| | Prognostic significance of Zinc finger E-box binding homeobox 1 (ZEB1) expression in cancer cells and cancer-associated fibroblasts in pancreatic head cancer. | Q38220284 |
| | A collective route to metastasis: Seeding by tumor cell clusters | Q38819905 |
| | Conversion to stem-cell state in response to microenvironmental cues is regulated by balance between epithelial and mesenchymal features in lung cancer cells | Q38823872 |
| | A self-enforcing CD44s/ZEB1 feedback loop maintains EMT and stemness properties in cancer cells. | Q38863828 |
| | CD44S-hyaluronan interactions protect cells resulting from EMT against anoikis | Q38879479 |
| | The GRHL2/ZEB Feedback Loop-A Key Axis in the Regulation of EMT in Breast Cancer. | Q38925675 |
| | Extracellular matrix density promotes EMT by weakening cell-cell adhesions | Q39028852 |
| | Alternative splicing of CD44 mRNA by ESRP1 enhances lung colonization of metastatic cancer cell. | Q39335846 |
| | Epithelial-mesenchymal transition, a spectrum of states: Role in lung development, homeostasis, and disease. | Q39395614 |
| | Targets of the tumor suppressor miR-200 in regulation of the epithelial-mesenchymal transition in cancer. | Q39460209 |
| | Bifurcation dynamics in lineage-commitment in bipotent progenitor cells | Q40148843 |
| | Matrix stiffness induces epithelial-mesenchymal transition and promotes chemoresistance in pancreatic cancer cells | Q41228738 |
| | Activation of Matrix Hyaluronan-Mediated CD44 Signaling, Epigenetic Regulation and Chemoresistance in Head and Neck Cancer Stem Cells. | Q41661288 |
| | The RNA-binding protein ESRP1 promotes human colorectal cancer progression | Q41835902 |
| | ZEB1 induces LOXL2-mediated collagen stabilization and deposition in the extracellular matrix to drive lung cancer invasion and metastasis. | Q42118077 |
| | Quantifying the landscape and kinetic paths for epithelial-mesenchymal transition from a core circuit. | Q42415653 |
| | Epithelial-mesenchymal transition induced by growth suppressor p12CDK2-AP1 promotes tumor cell local invasion but suppresses distant colony growth | Q43225336 |
| | CD44 variant isoforms promote metastasis formation by a tumor cell-matrix cross-talk that supports adhesion and apoptosis resistance. | Q46125902 |
| | Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Head and Neck Cancer | Q46249272 |
| | ESRP1 is overexpressed in ovarian cancer and promotes switching from mesenchymal to epithelial phenotype in ovarian cancer cells | Q47138140 |
| | Characterization of epithelial-mesenchymal transition intermediate/hybrid phenotypes associated to resistance to EGFR inhibitors in non-small cell lung cancer cell lines | Q47154025 |
| | Numb prevents a complete epithelial-mesenchymal transition by modulating Notch signalling. | Q47162554 |
| | Snail Driving Alternative Splicing of CD44 by ESRP1 Enhances Invasion and Migration in Epithelial Ovarian Cancer | Q47410084 |
| | Survival Outcomes in Cancer Patients Predicted by a Partial EMT Gene Expression Scoring Metric | Q47673602 |
| | SNAIL-induced epithelial-to-mesenchymal transition produces concerted biophysical changes from altered cytoskeletal gene expression. | Q48693733 |
| | Cell motility and ECM proteolysis regulate tumor growth and tumor relapse by altering the fraction of cancer stem cells and their spatial scattering. | Q50657054 |
| | The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer. | Q50724133 |
| | Operating principles of tristable circuits regulating cellular differentiation. | Q51034860 |
| | Phenotypic Plasticity, Bet-Hedging, and Androgen Independence in Prostate Cancer: Role of Non-Genetic Heterogeneity. | Q53078069 |
| | Different thresholds of ZEB1 are required for Ras-mediated tumour initiation and metastasis. | Q53227586 |
| | Identification of the tumour transition states occurring during EMT. | Q53693953 |
| | OVOL2 links stemness and metastasis via fine-tuning epithelial-mesenchymal transition in nasopharyngeal carcinoma. | Q54946015 |
| | Loss of inter-cellular cooperation by complete epithelial-mesenchymal transition supports favorable outcomes in basal breast cancer patients. | Q55072498 |
| | Heterogeneity of Human Breast Stem and Progenitor Cells as Revealed by Transcriptional Profiling. | Q55229889 |
| | RACIPE: a computational tool for modeling gene regulatory circuits using randomization. | Q55312547 |
| | Distinguishing mechanisms underlying EMT tristability | Q59615849 |
| | Pre-neoplastic pancreas cells enter a partially mesenchymal state following transient TGF-β exposure | Q88524981 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 3 | |
| P304 | page(s) | 031908 | |
| P577 | publication date | 2018-08-22 | |
| P1433 | published in | APL Bioengineering | Q73908397 |
| P1476 | title | Interconnected feedback loops among ESRP1, HAS2, and CD44 regulate epithelial-mesenchymal plasticity in cancer | |
| P478 | volume | 2 | |